AMGEN

Amgen main mission is to serve patients. Amgen is leader in Biotechnology industry, research and making Biotechnology Products. Company has over 22,000 employees as on 2020. Headquarters is in California, USA.

Amgen Prevents Infections in Cancer Patients Program to Launch Innovative Tools to Improve Patient-Provider Conversations

Amgen is dedicated to the fight against heart disease and has now launched Breakaway from Heart Disease™. The collective goal of this national campaign is to help make America’s heart health a priority.

Amgen believes in a “biology first” approach. Amgen use cutting-edge science and technology to study the subtlest biological mechanisms in search of therapies that will improve the lives of those who suffer from diseases. Amgen believes the cure for disease can be found inside each and every one of us.

Amgen annual revenue generated for period ending Dec-2021 was 25,979 million USD.

Split of Annual Revenue by business segment for period ending Dec-2021:

Product sales: 24,297 million USD.
Other revenues : 1,682 million USD.

Amgen annual net income generated for period ending Dec-2021 was 5,893 million USD.

Total Assets as on Dec-2021 was 61,165 Million USD

Annual Revenue

AMGEN Annual Revenues for December-2020 ending is 25.42 Billion USD

Annual Operating Income

9.14 Billion USD for Year ending December-2020

Annual Net Income

AMGEN Annual Net Income for December-2020 ending is 7.26 Billion USD

Total Current Assets

AMGEN Total Current Assets as on June-2020 is 22,895 Million USD

Total Assets

AMGEN Total Assets as on June-2020 is 65,011 Million USD

Total Current Liabilities

AMGEN Total Current Liabilities as on June-2020 is 10,523 Million USD

Total Liabilities

AMGEN Total Liabilities as on June-2020 is 54,352 Million USD

Total Equity

AMGEN Total Equity as on June-2020 is 10,659 Million USD

Annual Results Summary:

Amgen Inc - Yearly Results - Revenue and Net Profit - in Million USD:

Year - Ending	Revenue	Net Profit
Dec-2022	26,323	6,552
Dec-2021	25,979	5,893
Dec-2020	25,424	7,264
Dec-2019	23,362	7,842
Dec-2018	23,747	8,394
Dec-2017	22,849	1,979
Dec-2016	22,991	7,722

Balance Sheet Summary

Amgen Inc - Balance Sheet Summary - in Million USD:

Year Ending:	Total Assets	Total Liabilities	Total Equity
Dec-2022	65,121	61,460	3,661
Dec-2021	61,165	54,465	6.700
Dec-2020	62,948	53,539	9,409
Dec-2019	59,707	50,034	9,673
Dec-2018	66,416	53,916	12,500
Dec-2017	79,954	54,713	25,241
Dec-2016	77,626	47,751	29,875

Quarterly Results Summary:

Amgen Inc - Quarterly Results - Revenue and Net Profit - in Million USD:

Quarter - Ending	Revenue	Net Profit
Dec-2022	6,839	1,616
Sep-2022	6,652	2,143
Jun-2022	6,594	1,317
Mar-2022	6,238	1,476
Dec-2021	6,846	1,899
Sep-2021	6,706	1,884
Jun-2021	6,526	464
Mar-2021	5,901	1,646
Dec-2020	6,634	1,615
Sep-2020	6,423	2,021
Jun-2020	6,206	1,803
Mar-2020	6,161	1,825
Dec-2019	6,197	1,703
Sep-2019	5,737	1,968
Jun-2019	5,871	2,179
Mar-2019	5,557	1,992
Dec-2018	6,230	1,928
Sep-2018	5,904	1,859

Institutional Investors

Top 25 Institutional Investors in AMGEN as on Jun-30-2020

Rank	INVESTOR NAME	DATE	SHARES HELD	CHANGE (SHARES)	CHANGE (%)	VALUE (IN 1,000S)
1	VANGUARD GROUP INC	6/30/2020	48,866,168	-778,987	-1.57%	$12,071,409
2	BLACKROCK INC.	6/30/2020	48,729,584	2,267,217	4.88%	$12,037,669
3	CAPITAL RESEARCH GLOBAL INVESTORS	6/30/2020	33,361,674	251,029	0.76%	$8,241,334
4	STATE STREET CORP	6/30/2020	26,262,358	55,408	0.21%	$6,487,590
5	PRIMECAP MANAGEMENT CO/CA/	6/30/2020	17,962,930	-517,160	-2.80%	$4,437,383
6	FMR LLC	6/30/2020	17,094,295	-552,358	-3.13%	$4,222,804
7	GEODE CAPITAL MANAGEMENT, LLC	6/30/2020	10,029,477	-87,724	-0.87%	$2,477,582
8	NORDEA INVESTMENT MANAGEMENT AB	6/30/2020	8,358,990	3,911,383	87.94%	$2,064,921
9	MORGAN STANLEY	6/30/2020	8,004,598	740,763	10.20%	$1,977,376
10	NORTHERN TRUST CORP	6/30/2020	7,978,410	-4,782	-0.06%	$1,970,907
11	WELLS FARGO & COMPANY/MN	6/30/2020	7,449,684	276,284	3.85%	$1,840,295
12	BANK OF AMERICA CORP /DE/	6/30/2020	7,157,561	-645,072	-8.27%	$1,768,132
13	JPMORGAN CHASE & CO	6/30/2020	6,878,380	2,380,375	52.92%	$1,699,166
14	BANK OF NEW YORK MELLON CORP	6/30/2020	6,683,250	171,906	2.64%	$1,650,963
15	NORGES BANK	12/31/2019	6,285,274	-414,595	-6.19%	$1,552,651
16	CLEARBRIDGE INVESTMENTS, LLC	6/30/2020	5,654,954	1,536,197	37.30%	$1,396,943
17	CAPITAL INTERNATIONAL INVESTORS	6/30/2020	4,110,420	-1,589,967	-27.89%	$1,015,397
18	ARISTOTLE CAPITAL MANAGEMENT, LLC	6/30/2020	4,108,610	190,968	4.88%	$1,014,950
19	LEGAL & GENERAL GROUP PLC	6/30/2020	4,023,019	154,051	3.98%	$993,806
20	NUVEEN ASSET MANAGEMENT, LLC	6/30/2020	3,901,641	166,076	4.45%	$963,822
21	WELLINGTON MANAGEMENT GROUP LLP	6/30/2020	3,843,171	-211,398	-5.21%	$949,379
22	DEUTSCHE BANK AG\	6/30/2020	3,730,196	-241,267	-6.08%	$921,470
23	ROYAL BANK OF CANADA	6/30/2020	3,598,646	-162,592	-4.32%	$888,974
24	PRICE T ROWE ASSOCIATES INC /MD/	6/30/2020	3,567,079	-867,966	-19.57%	$881,176
25	UBS ASSET MANAGEMENT AMERICAS INC	6/30/2020	3,424,168	403,228	13.35%	$845,872

AMGEN

Amgen Inc - Yearly Results - Revenue and Net Profit - in Million USD:

Amgen Inc - Balance Sheet Summary - in Million USD:

Amgen Inc - Quarterly Results - Revenue and Net Profit - in Million USD:

Top 25 Institutional Investors in AMGEN as on Jun-30-2020

Share it on Social Media